Floatz logo

METHOTREXATE

Testicular Leukemia

Children's Oncology GroupSmall moleculePhase 3Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

14 Active assets in the Testicular Leukemia cohort.

Asset / SponsorPhaseRating
THIOGUANINE ANHYDROUS
Children's Oncology Group
Phase 3BB
VINCRISTINE SULFATE
Children's Oncology Group
Phase 3BB
Cytosin-Arabinosid
Children's Oncology Group
Phase 3BB
Daunorubicin
Children's Oncology Group
Phase 3BB
PREDNISONE TABLETS
Children's Oncology Group
Phase 3BB

View all 18 →

Same molecule, other indications

METHOTREXATE is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →
acute promyelocytic leukemiaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →